Advances in Biliary Tract Disorders: Novel Biomarkers, Pharmacotherapies, Endoscopic Techniques, and Surgical Management
1Mayo Clinic, Rochester, USA
2University of North Dakota, North Dakota, USA
3University Hospital Birmingham, Birmingham, UK
4University of California at Davis, California, USA
Advances in Biliary Tract Disorders: Novel Biomarkers, Pharmacotherapies, Endoscopic Techniques, and Surgical Management
Description
The “cholangiopathies” refer to an etiologically diverse group of human diseases affecting or originating in the biliary tract. As a group, these conditions account for an enormous amount of the morbidity and mortality of all liver diseases and are a common indication for orthotopic liver transplantation. Therefore, it is not surprising that the cholangiopathies represent an area of intense ongoing research and discovery.
To promote dissemination of recent knowledge and developments in the field, including at a basic, translational, clinical, endoscopic, and outcomes level, we invite investigators to contribute original research articles as well as review articles that will stimulate the continuing efforts to understand the mechanisms, conversion, production, and management related to both benign and malignant diseases of the biliary tract.
Potential topics include, but are not limited to:
- Pathogenesis/mechanisms of disease
- Epidemiology
- Diagnostic testing/biomarkers
- Therapeutic approaches and management (pharmacologic, endoscopic, or other)
- Indications for and novel developments in surgical management
- Liver transplantation for diseases of the biliary tract
- Disease surveillance